Article: Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference.(Conference news)

NOVATO, California, November 5 /PRNewswire/ --

- Proof-of-Concept Data at 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain

Raptor Pharmaceutical Corp. (Nasdaq: RPTP), today announced that data from a clinical trial of NGX426, the Company's orally administered non-opioid, AMPA/kainate antagonist, will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November 20-21, 2009 in San Francisco.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Mark Wallace, M.D., Professor of Clinical Anesthesiology at the Center for Pain Medicine of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!